Olanzapine vs placebo for nausea from first chemo
Treatments studied
Part of Cancer, Digestive system clinical trials.
This study tests if the drug olanzapine (commonly used for nausea) can help prevent vomiting in people receiving moderately strong chemotherapy for the first time. It may be a good fit if you're about to start treatment with oxaliplatin, irinotecan, or carboplatin and haven't had severe nausea treatments before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cancer and are starting a new chemotherapy with oxaliplatin, irinotecan, or carboplatin for the first time.
- You are 18 years or older.
- You are not pregnant or breastfeeding.
- You have not vomited in the last 24 hours.
- You do not have a bowel blockage, uncontrolled brain tumors, or severe liver/kidney problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether the drug olanzapine can help improve appetite and reduce weight loss in people with advanced cancer who are not currently receiving chemotherapy or other anti-cancer treatment. It may be an option if you have lost weight and have little appetite.
This trial tests if combining two anti-nausea drugs (olanzapine and palonosetron) can prevent vomiting and nausea without using steroids in people receiving high-dose cisplatin chemotherapy for their first time.
This trial tests if adding olanzapine to standard anti-nausea medicines can better prevent vomiting in children and teens who still vomit despite current treatment. It aims to help those aged 5 to 18 receiving strong chemotherapy.
This trial tests whether a medication called olanzapine can help reduce nausea and loss of appetite in patients receiving chemotherapy before surgery for stomach cancer. The goal is to help you feel better and maintain nutrition during your cancer treatment.
This study tests whether olanzapine, a medication that can increase appetite, helps prevent severe appetite loss and muscle wasting in patients with ovarian or stomach cancer who are receiving chemotherapy before surgery. The goal is to help patients maintain nutrition and strength during treatment.
This study tests whether the combination of olanzapine and metoclopramide can prevent nausea and vomiting caused by strong painkillers (opioids) in people with advanced cancer. If you are starting a strong opioid for pain and have not had nausea or vomiting recently, this study may be for you.
Hear when a new Chemotherapy-induced Nausea and Vomiting trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.